Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

enVVeno Medical Corp.

10.35
+0.06000.58%
Post-market: 10.560.2050+1.98%16:10 EDT
Volume:20.28K
Turnover:216.05K
Market Cap:7.07M
PE:-0.42
High:11.41
Open:10.59
Low:10.30
Close:10.29
52wk High:36.05
52wk Low:8.67
Shares:682.70K
Float Shares:563.60K
Volume Ratio:0.93
T/O Rate:3.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.8994
EPS(LYR):-33.0600
ROE:-58.53%
ROA:-36.67%
PB:0.34
PE(LYR):-0.31

Loading ...

OverviewCompanyNewsFilings

enVVeno Medical wins FDA IDE approval for US pivotal venous valve study

Reuters
·
May 12

enVVeno Medical Q1 EPS $(5.89) Misses $(0.28) Estimate

Benzinga Earnings
·
May 07

enVVeno Q1 FY26 net loss narrows 15% to $3.8 million

Reuters
·
May 07

enVVeno Medical Corp - Clinical Site Activation and Patient Enrollment Expected to Begin Later This Year - SEC Filing

THOMSON REUTERS
·
Apr 29

enVVeno Medical Corp - Has About $25 Mln in Cash and Investments to Fund Operations Into Q3 2027 - SEC Filing

THOMSON REUTERS
·
Apr 29

enVVeno Medical Receives First-Ever FDA Ide Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve

THOMSON REUTERS
·
Apr 29

enVVeno Medical wins FDA IDE approval for U.S. pivotal trial of enVVe venous valve

Reuters
·
Apr 29

enVVeno Medical Q4 EPS $(6.05) Misses $(0.30) Estimate

Benzinga Earnings
·
Mar 27

enVVeno Medical FY2025 net loss narrows 11% to $20 million; revenue logs no revenue

Reuters
·
Mar 27

enVVeno Medical Director Francis Duhay Disposes of Common Shares

Reuters
·
Mar 14

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Jul 30, 2026 Post-Mkt
Financial Report Announcement
May 06, 2026 Post-Mkt
Financial Report Announcement
Mar 26, 2026 Post-Mkt
Split&Reverse Split
Jan 20, 2026 35 for 1
Financial Report Announcement
Oct 30, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.42
Current
-2.45
Sector Average
85.29%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.42
Maximum
-0.27
+1 STD
-0.85
Minimum
-7.73
-1 STD
-4.04
Average
-2.45

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.